Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradermal vs. Intramuscular Influenza Vaccine in Elders
NCT00504231Phase 2Completed
- Sponsor
- PATH
- Start
- Sep 2007
- Primary completion
- Jan 2008
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 2 trial of Fluzone Trivalent in influenza, sponsored by PATH. Started Sep 2007; status: completed.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00504231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00504231.